Author + information
- aDivision of Cardiovascular Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
- bDivision of Cardiovascular Medicine, University of Cincinnati, Cincinnati, Ohio
- cDepartment of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin
- ↵∗Address for correspondence:
Dr. Evan C. Klein, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226.
A 56-year-old man with multiple cardiac manifestations of type 1 myotonic dystrophy, including severe, nonischemic cardiomyopathy, presented in refractory cardiogenic shock requiring inotropic therapy. Given his wishes to die without having any intravenous medications, he was started on oral probenecid therapy, which allowed for successful elimination of his intravenous therapies. (Level of Difficulty: Intermediate.)
Dr. Rubinstein is a founding member of CinTRYP; LLC; and has received royalties from this venture. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received April 12, 2019.
- Revision received June 27, 2019.
- Accepted July 7, 2019.
- 2019 The Authors